BioSpace News Archive

Business

Sumitovant Biopharma Created and Launched as Sumitomo Dainippon Pharma and Roivant Sciences Close Transaction for Strategic Alliance

Sumitomo Dainippon Pharma and Roivant Sciences complete strategic alliance and formation of new company, Sumitovant Biopharma, a wholly owned subsidiary of Sumitomo Dainippon Pharma

December 30, 2019
·
6 min read
Myovant Sciences Announces Closing of $400 Million Loan Facility, Repayment of Debt, Board of Director Transitions, and Executive Promotions

Low-interest (3-month LIBOR plus 3%) loan facility from Sumitomo Dainippon Pharma increased to allow repayment of pre-existing debt

December 30, 2019
·
6 min read
Biotech Bay

Agilent Compliance Services Voted No. 1 in Global Survey

Cell Associates conducted a survey for Agilent Technologies to the readers of LCGC, the leading magazine of separation science.

December 30, 2019
·
2 min read
Drug Development

Clover Biopharmaceuticals Initiates Phase III Study of Etanercept Biosimilar Candidate SCB-808 in China

The Phase III, multi-center trial in China is designed to assess the efficacy, safety and pharmacokinetics of SCB-808 and originator drug Enbrel® in patients with ankylosing spondylitis (radiographic axial spondyloarthritis) via subcutaneous administration.

December 30, 2019
·
3 min read
Genetown

Zacks Small Cap Research Releases Updated Report on Pressure BioSciences, Inc.

The Company does not by its reference to the research prepared by Zacks SCR imply its endorsement or adoption of or concurrence with such information, conclusions, or recommendations.

December 30, 2019
·
4 min read
Pharm Country

Cellular Biomedicine Group Announces Engagement of Independent Advisors by Special Committee

There is no formal timetable for the Special Committee process for evaluating potential strategic alternatives.

December 30, 2019
·
3 min read
Business

Aesthetic Medical International Holdings Group Limited Announces Openings of Two New Satellite Clinics

The Company invited certain local VIP customers to attend the opening ceremony and marketing sales event on December 28, 2019.

December 30, 2019
·
2 min read
Genetown

Hologic Completes Divestiture of Cynosure Medical Aesthetics Business

Hologic, Inc. (Nasdaq: HOLX) announced today that it has completed the previously announced divestiture of its Cynosure medical aesthetics business to an affiliate of investment funds managed by Clayton, Dubilier & Rice for a total purchase price of $205 million in cash, less certain closing adjustments

December 30, 2019
·
1 min read
AgriCann Solutions Enters into Binding Letter of Intent

AgriCann Solutions Corp. (the “Company”, “AgriCann” or “ASC”) is pleased to announce entering into a binding Letter of Intent (“LOI”) with CannaHoldCo, Inc.

December 30, 2019
·
6 min read
Biotech Bay

Varian to Present at the 38th J.P. Morgan Healthcare Conference

Varian announced that Dow Wilson, chief executive officer, and Chris Toth, president of Oncology Systems, will present at the J.P. Morgan Healthcare Conference in San Francisco, scheduled for 10:30 a.m. Pacific Time on Monday, January 13, 2020.

December 30, 2019
·
1 min read